141 related articles for article (PubMed ID: 8518547)
1. A linear model relating breath concentrations to environmental exposures: application to a chamber study of four volunteers exposed to volatile organic chemicals.
Wallace L; Pellizzari E; Gordon S
J Expo Anal Environ Epidemiol; 1993; 3(1):75-102. PubMed ID: 8518547
[TBL] [Abstract][Full Text] [Related]
2. Uptake and decay of volatile organic compounds at environmental concentrations: application of a four-compartment model to a chamber study of five human subjects.
Wallace LA; Nelson WC; Pellizzari ED; Raymer JH
J Expo Anal Environ Epidemiol; 1997; 7(2):141-63. PubMed ID: 9185009
[TBL] [Abstract][Full Text] [Related]
3. Elimination of volatile organic compounds in breath after exposure to occupational and environmental microenvironments.
Raymer JH; Pellizzari ED; Thomas KW; Cooper SD
J Expo Anal Environ Epidemiol; 1991 Oct; 1(4):439-51. PubMed ID: 1824328
[TBL] [Abstract][Full Text] [Related]
4. Elimination kinetics of volatile organics in humans using breath measurements.
Pellizzari ED; Wallace LA; Gordon SM
J Expo Anal Environ Epidemiol; 1992; 2(3):341-55. PubMed ID: 1422163
[TBL] [Abstract][Full Text] [Related]
5. Reconstructing week-long exposures to volatile organic compounds using physiologically based pharmacokinetic models.
Roy A; Georgopoulos PG
J Expo Anal Environ Epidemiol; 1998; 8(3):407-22. PubMed ID: 9679220
[TBL] [Abstract][Full Text] [Related]
6. Use of a physiologically based model to predict systemic uptake and respiratory elimination of perchloroethylene.
Dallas CE; Muralidhara S; Chen XM; Ramanathan R; Varkonyi P; Gallo JM; Bruckner JV
Toxicol Appl Pharmacol; 1994 Sep; 128(1):60-8. PubMed ID: 8079355
[TBL] [Abstract][Full Text] [Related]
7. Toxic volatile organic compounds in simulated environmental tobacco smoke: emission factors for exposure assessment.
Daisey JM; Mahanama KR; Hodgson AT
J Expo Anal Environ Epidemiol; 1998; 8(3):313-34. PubMed ID: 9679214
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in measuring exhaled breath and estimating exposure and body burden for volatile organic compounds (VOCs).
Wallace LA; Pellizzari ED
Environ Health Perspect; 1995 Apr; 103 Suppl 3(Suppl 3):95-8. PubMed ID: 7635121
[TBL] [Abstract][Full Text] [Related]
9. Variability of environmental exposures to volatile organic compounds.
Rappaport SM; Kupper LL
J Expo Anal Environ Epidemiol; 2004 Jan; 14(1):92-107. PubMed ID: 14726948
[TBL] [Abstract][Full Text] [Related]
10. Respiratory symptoms and peak expiratory flow in children with asthma in relation to volatile organic compounds in exhaled breath and ambient air.
Delfino RJ; Gong H; Linn WS; Hu Y; Pellizzari ED
J Expo Anal Environ Epidemiol; 2003 Sep; 13(5):348-63. PubMed ID: 12973363
[TBL] [Abstract][Full Text] [Related]
11. NTP Toxicology and Carcinogenesis Studies of Talc (CAS No. 14807-96-6)(Non-Asbestiform) in F344/N Rats and B6C3F1 Mice (Inhalation Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 421():1-287. PubMed ID: 12616290
[TBL] [Abstract][Full Text] [Related]
12. Toxicology and carcinogenesis studies of indium phosphide (CAS No. 22398-90-7) in F344/N rats and B6C3F1 mice (inhalation studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2001 Jul; (499):7-340. PubMed ID: 12087422
[TBL] [Abstract][Full Text] [Related]
13. Breath measurements as volatile organic compound biomarkers.
Wallace L; Buckley T; Pellizzari E; Gordon S
Environ Health Perspect; 1996 Oct; 104 Suppl 5(Suppl 5):861-9. PubMed ID: 8933027
[TBL] [Abstract][Full Text] [Related]
14. Relationships between levels of volatile organic compounds in air and blood from the general population.
Lin YS; Egeghy PP; Rappaport SM
J Expo Sci Environ Epidemiol; 2008 Jul; 18(4):421-9. PubMed ID: 18059425
[TBL] [Abstract][Full Text] [Related]
15. Methods development for epidemiologic investigations of the health effects of prolonged ozone exposure. Part II. An approach to retrospective estimation of lifetime ozone exposure using a questionnaire and ambient monitoring data (California sites).
Tager IB; Künzli N; Lurmann F; Ngo L; Segal M; Balmes J
Res Rep Health Eff Inst; 1998 Mar; (81):27-78; discussion 109-21. PubMed ID: 9643947
[TBL] [Abstract][Full Text] [Related]
16. Use of a physiologically based pharmacokinetic model to identify exposures consistent with human biomonitoring data for chloroform.
Tan YM; Liao KH; Conolly RB; Blount BC; Mason AM; Clewell HJ
J Toxicol Environ Health A; 2006 Sep; 69(18):1727-56. PubMed ID: 16864423
[TBL] [Abstract][Full Text] [Related]
17. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
Marsman D
Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
[TBL] [Abstract][Full Text] [Related]
18. Relationships of Indoor, Outdoor, and Personal Air (RIOPA). Part I. Collection methods and descriptive analyses.
Weisel CP; Zhang J; Turpin BJ; Morandi MT; Colome S; Stock TH; Spektor DM; Korn L; Winer AM; Kwon J; Meng QY; Zhang L; Harrington R; Liu W; Reff A; Lee JH; Alimokhtari S; Mohan K; Shendell D; Jones J; Farrar L; Maberti S; Fan T
Res Rep Health Eff Inst; 2005 Nov; (130 Pt 1):1-107; discussion 109-27. PubMed ID: 16454009
[TBL] [Abstract][Full Text] [Related]
19. Update of potency factors for asbestos-related lung cancer and mesothelioma.
Berman DW; Crump KS
Crit Rev Toxicol; 2008; 38 Suppl 1():1-47. PubMed ID: 18671157
[TBL] [Abstract][Full Text] [Related]
20. Development of a screening approach to interpret human biomonitoring data on volatile organic compounds: reverse dosimetry on biomonitoring data for trichloroethylene.
Liao KH; Tan YM; Clewell HJ
Risk Anal; 2007 Oct; 27(5):1223-36. PubMed ID: 18076492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
